Foster Dykema Cabot & Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12K Sell
167
-4,873
-97% -$459K ﹤0.01% 258
2026
Q1
$596K Sell
5,040
-100
-2% -$12.4K 0.04% 66
2025
Q4
$647K Buy
5,140
+20
+0.4% +$2.61K 0.04% 67
2025
Q3
$749K Hold
5,120
0.05% 66
2025
Q2
$798K Buy
5,120
+10
+0.2% +$1.59K 0.06% 60
2025
Q1
$841K Sell
5,110
-10
-0.2% -$1.66K 0.07% 51
2024
Q4
$834K Buy
5,120
+9
+0.2% +$1.61K 0.07% 55
2024
Q3
$999K Buy
5,111
+100
+2% +$18.4K 0.08% 48
2024
Q2
$869K Sell
5,011
-1
-0% -$166 0.08% 43
2024
Q1
$848K Buy
5,012
+1,228
+32% +$230K 0.08% 44
2023
Q4
$747K Buy
+3,784
New +$670K 0.08% 45

Other funds holding ZTS

Foster Dykema Cabot & Partners's ZTS Position: Q2 2026 in Review

Foster Dykema Cabot & Partners reduced its Zoetis (ZTS) stake by 97% in Q2 2026, selling an estimated $459K and leaving 167 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #258.

Foster Dykema Cabot & Partners first reported a position in ZTS in Q4 2023 and has held it in 11 quarters since. The position peaked at $999K in Q3 2024. 1,429 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Foster Dykema Cabot & Partners held 167 shares of Zoetis worth $12K as of Q2 2026.
  • Foster Dykema Cabot & Partners sold 4,873 Zoetis shares in Q2 2026, an estimated $459K.
  • Zoetis made up ﹤0.01% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #258 holding.
  • Foster Dykema Cabot & Partners first reported a position in Zoetis in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Zoetis position peaked at $999K in Q3 2024.
  • 1,429 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.